Join our new live webinar on January 17th: the FDA has launched their online portal for product listing and facility registration
News
Live Roundtable: Cosmetics Regulatory Changes in Europe, United States, and China
Get ready for an exciting collaboration as Obelis Group and Cosmetics Europe – The Personal Care Association come together to present an engaging roundtable discussion on December 7, 2023.
Live Webinar: US-based cosmetics companies – how to comply with MoCRA
Join our newt live webinar on December 4th: US – based companies – what the latest information from the FDA means for you
Webinar: MHRA and Clinical Testing (with the collaboration of Qmed Consulting A/S)
Watch our new webinar about MHRA and Clinica Testing with the Qmed Consulting A/S
Webinar: Non-US based cosmetics companies – how to comply with MoCRA
Join our newt live webinar on November 15th: Non-US based companies – how to comply with MoCRA
Webinar: US-based cosmetics companies – how to comply with MoCRA
Join our newt live webinar on October 31st: US – based companies – how to comply with MoCRA
Compliance Success Stories: Home and Body Company – Building Trust Through Compliance for International Expansion
Explore Home and Body Co’s exceptional path through cosmetic compliance and how their partnership with Obelis Regulatory Services enabled international growth while maintaining a strong focus on product safety and regulatory excellence.
New Free Sales Certificate under MDR & IVDR for EU non-EU manufacturers!
The Belgian competent authority (AFMPS/FAGG) has updated the form for the Free Sales Certificates (FSC) under the Medical Devices Regulation 2017/745 (MDR) and the In Vitro Diagnostic Devices Regulation 2017/746 (IVDR).
MoCRA terminology: an insight into the main terms of the new American law on cosmetics
Learn the main terms of the new American law on cosmetics: MoCRA.
Contract manufacturers and brand owners: what has changed with MoCRA
MoCRA has ushered in significant changes for cosmetic brand owners and contract manufacturers, necessitating the revision of agreements and the establishment of clear responsibilities to meet the new regulatory standards.